97 results on '"Grohé Christian"'
Search Results
2. Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP).
3. Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
4. Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?
5. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms.
6. Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial.
7. Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study.
8. Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study.
9. Correlation of respiratory muscle function and cardiopulmonary exercise testing in post-acute COVID-19 syndrome.
10. Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry.
11. Arthritiden und Lungenkavernen.
12. Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.
13. Post-COVID und die Lunge.
14. Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.
15. Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.
16. Update 2021: Pulmonale Folgen nach COVID-19-Pneumonie.
17. Optimizing therapy sequence to prevent patient attrition in EGFR mutation-positive advanced or metastatic NSCLC.
18. Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis.
19. COVID-19 aus Sicht der Pneumologie – Langzeitfolgen und Implikationen für die pneumologische Nachsorge.
20. Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort.
21. Begutachtung von Berufskrankheiten am Beispiel pneumologischer Erkrankungen.
22. Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinoma.
23. Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.
24. Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
25. Hyponatremia in Oncology Patients.
26. Neuroendokrine Neoplasien im deutschen NET-Register.
27. Kommentar.
28. Intersektorale Konzepte zur außerklinischen Beatmung.
29. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.
30. Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.
31. SIADH: differential diagnosis and clinical management.
32. Aktuelle Therapieansätze der Sarkoidose.
33. Lingua Villosa Nigra Following Initiation of Antibiotic Treatment for Multidrug-Resistant Tuberculosis.
34. ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study.
35. Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
36. Die Zeitenwende der chronisch fibrosierenden Lungengerüsterkrankung.
37. Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.
38. Sex and Gender Differences in Pulmonary Diseases.
39. Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib.
40. Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany.
41. TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo.
42. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
43. A Novel Sarcoidosis Risk Locus for Europeans on Chromosome 11q13.1.
44. Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study.
45. VEGF Gene Haplotypes Are Associated With Sarcoidosis.
46. Lack of gelsolin promotes perpetuation of atrial fibrillation in the mouse heart.
47. Toll-Like Receptor 2 Gene Polymorphisms Arg677Trp and Arg753Gln in Chronic Obstructive Pulmonary Disease.
48. Polymorphisms of the ß2 adrenoreceptor gene in chronic obstructive pulmonary disease.
49. Sex-specific pathways in early cardiac response to pressure overload in mice.
50. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.